T

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Executive Director of Insights and Analytics

Data ScienceConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$275.2k - $412.8k

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 15 years of progressive experience in pharmaceutical or biotechnology insights, analytics, forecasting, or related commercial operations roles is required.
  • Deep oncology expertise and a proven track record of leading analytics for oncology or specialty product launches are required.
  • A proven track record of building, scaling, and developing high-performing analytics and insights organizations from the ground up is required.
  • Deep understanding of the global and U.S. oncology market landscape, patient journeys, clinical treatment pathways, and competitive dynamics is required.
  • Expertise in pharmaceutical data sources, including claims, electronic health records, and specialty distribution data, and in translating analytics into business action is required.
  • Executive presence and communication skills, including the ability to influence C-level peers and present data-driven narratives, are required.
  • Managerial courage and a proven ability to attract, develop, and retain analytics and data science talent are required.

Responsibilities

  • Serve as a core member of cross-functional teams and act as the strategic anchor for market analysis, competitive landscape evaluation, and commercial insights.
  • Partner with Medical Affairs, Market Access, Finance, Marketing, and Clinical Development to align evidence needs, performance key performance indicators, and corporate strategies.
  • Synthesize complex data into an overview of commercial strategy, opportunities, and risks for the Executive Leadership Team and Board of Directors.
  • Direct the Market Research function to generate insights from healthcare professionals, patients, and payers to shape brand strategy and product positioning.
  • Establish a proactive competitive intelligence capability to track the competitive landscape, clinical developments, reimbursement trends, and disruptive innovations in oncology.
  • Provide strategic oversight in developing global forecasting models for marketed products and pipeline assets.
  • Lead scenario planning, demand models, sensitivity analyses, and pipeline handover strategies to inform long-range planning, investment allocation, and launch readiness.
  • Lead the Data & Advanced Analytics Center of Excellence in developing enterprise data strategy for acquisition, integration, governance, and quality, and drive adoption of predictive modeling and AI-enabled decision-making.
  • Oversee evaluation, procurement, and integration of commercial oncology data assets, including specialty pharmacy, claims, electronic health record, payer, and real-world evidence sources.
  • Establish performance analytics and executive dashboarding capabilities, transitioning the organization from static reporting to dynamic, predictive, and action-oriented intelligence.
  • Build and mentor a high-performing leadership team across Market Research, Forecasting, and the Data & Advanced Analytics Center of Excellence.

Desired Qualifications

  • An advanced degree such as an MBA, MS, MPH, PharmD, PhD, or a degree in a related discipline is strongly preferred.

About the Company

Tango Therapeutics

Develops synthetic-lethality cancer therapies

Tango Therapeutics develops cancer medicines by leveraging synthetic lethality to selectively kill cancer cells while sparing healthy cells. Its approach focuses on creating drugs that exploit interactions between gene pairs, aiming for targeted therapies that spare normal tissue. The company advances its treatments through a strong R&D program and collaborates with larger pharmaceutical partners, such as Gilead Sciences, to co-develop therapies and accelerate commercialization. Revenue comes from these partnerships and funding rounds like its Series B. Tango differentiates itself with a dedicated emphasis on genetically targeted cancer therapies, a robust pipeline, and leadership that guides strategic collaborations. The company’s goal is to bring next-generation, genetically targeted immunotherapies to market, improving outcomes for cancer patients by precisely targeting tumor biology.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Tango Therapeutics

See more jobs